The Department of Health and Human Services (HHS) has announced a plan to end mRNA vaccine work funded by the Biomedical Advanced Research and Development Authority (BARDA), a major escalation of ...
Looking to fill a treatment gap, the U.S. Biomedical Advanced Research and Development Authority (BARDA) is launching the first stage of a $100 million prize competition to support development of ...
(RTTNews) - OraSure Technologies, Inc. (OSUR), a medical device company, on Monday announced that it has secured funding from the U.S. Department of Health and Human Services' Biomedical Advanced ...
As the Trump administration continues to pivot away from vaccinations, it is pushing for the development of new antiviral therapies via the launch of a $100 million competition. The inaugural Small ...
GE HealthCare Technologies Inc. GEHC recently announced a $35 million expansion to its prior contract with the Biomedical Advanced Research and Development Authority (“BARDA”). The expanded contract ...
NEW YORK--(BUSINESS WIRE)--CastleVax, a clinical stage mucosal vaccine platform company, has received an additional Project NextGen award valued at approximately $34 million to support the continued ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results